Pleurodesis by erythromycin, tetracycline, AerosilTM 200, and erythromycin plus AerosilTM 200 in a rat model: a preliminary study
Pleurodesis by erythromycin, tetracycline, AerosilTM 200, and erythromycin plus AerosilTM 200 in a rat model: a preliminary study
نویسندگان: شهریار هاشم زاده , خسرو هاشم زاده , کامران ممقانی , راحله علیقلی پور ملکی , صمد اسلام جمال گلزاری , کامیار قابیلی
کلمات کلیدی: AerosilTM 200, Erythromycin, Pleurodesis, Silicon dioxide, Tetracycline
نشریه: 8977 , 1 , 20 , 2012
| نویسنده ثبت کننده مقاله |
صمد اسلام جمال گلزاری |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات قلب وعروق |
| کد مقاله |
69081 |
| عنوان فارسی مقاله |
Pleurodesis by erythromycin, tetracycline, AerosilTM 200, and erythromycin plus AerosilTM 200 in a rat model: a preliminary study |
| عنوان لاتین مقاله |
Pleurodesis by erythromycin, tetracycline, AerosilTM 200, and erythromycin plus AerosilTM 200 in a rat model: a preliminary study |
| ناشر |
7 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
خیر |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Background: None of the current pleurodesing agents fulfil all the criteria for best pleural sclerosant. Therefore, the
search for the ideal agent for chemical pleurodesis still continues. The aim of the present study was to compare the
effectiveness of erythromycin, tetracycline, AerosilTM 200 (hydrophilic fumed amorphous silica), and erythromycin
plus AerosilTM 200 in producing pleurodesis in rats. In the present study, talc was not used as a pleurodesing agent
due to an unavailability of its sterile and pure form in Iran.
Methods: Overall, 75 adult male Spraque-Dawley rats were randomized to 5 treatment groups. Each group
received an intrapleural injection via 5 Fr Silastic tubes of one of the following sterile agents: 35mg/kg erythromycin
in 2 ml of saline, 35mg/kg tetracycline in 2 ml of saline, 35mg/kg AerosilTM 200 in 2ml of saline, erythromycin
(35mg/kg in 2 ml of saline) plus AerosilTM 200 (35mg/kg in 2 ml of saline), or 2 ml of saline as a control. The animals
were euthanized and necropsied 30 days after injection. The pleurae were assessed for macroscopic and
microscopic evidence of surrounding inflammation and fibrosis.
Results: The median macroscopic score in the AerosilTM 200 group was significantly higher than that in the
erythromycin group (P < 0.005). The median microscopic score in the erythromycin group was significantly lower
than that in the AerosilTM 200 and erythromycin plus AerosilTM 200 groups (P < 0.005). Furthermore, maximum and
minimum pleural fibrosis was observed in the erythromycin plus AerosilTM 200 and erythromycin groups,
respectively (P < 0.05).
Conclusion: This study suggests that AerosilTM 200 with or without erythromycin may be more potent pleurodesis
agent than erythromycin and tetracycline. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| O-Pleurodesis.pdf | 1398/07/06 | 236865 | دانلود |